对脂肪肝患者实施健康管理的临床价值探讨.docxVIP

对脂肪肝患者实施健康管理的临床价值探讨 罗晓岚 曾媛 杨华升 摘要 目的 探讨对脂肪肝患者实施健康管理的临床价值。方法 以我院20XX年10月—20XX年10月间诊疗的中度脂肪肝患者为研究对象，根据组间均衡可比的原则选择观察组与对照组，每组60例。对照组进行常规指导，定期随访;观察组在此基础上实施跟踪健康管理1年，比较两组患者病情发展情况以及生存质量。结果 实施健康管理1年后，观察组中度脂肪肝转为轻度脂肪肝23例（38.33%），转为重度脂肪肝10例（16.67%），与对照组相比，差异有统计学意义（P0.05）;观察组健康生活状况调查量表（SF-36）得分高于对照组，两组比较差异有统计学意义（P0.05）。观察组体质量指数（BMI）、肝功能、血脂、受控衰减参数（CAP）值均低于对照组，两组比较差异有统计学意义（P0.05）。结论 通过实施跟踪健康管理，可有效控制脂肪肝患者病情发展，并可改善其生存质量。 关键词 脂肪肝;健康管理;生存质量 中图分类号 R473.5 文献标识码 A 文章编号 1671-0223（2020）14-074-04 Abstract Objective To explore the clinical value of health management for patients with fatty liver.Methods Taking the patients with moderate fatty liver diagnosed and treated in our hospital from October 20XX to October 20XX as the research object， the observation group and the control group were selected according to the principle of balanced and comparable between groups， with 60 cases in each group.The control group received routine guidance and regular follow-up， and the observation group was followed up for 1 year on this basis ， and compared the disease development and quality of life in the two groups.Results One year after the implementation of health management， 23 cases （38.33%） of moderate fatty liver conversion to mild fatty liver and 10 cases （16.67%） conversion to severe fatty liver in the observation group， the difference was statistically significant （P0.05），The SF-36 score of the observation group was higher than that of the control group， and the difference was statistically significant （P0.05）. BMI， liver function， blood lipid and cap of the observation group were lower than those of the control group （P0.05）.Conclusion The follow-up health management can effectively control the development of fatty liver， keep the disease in a relatively stable state， and improve the quality of life for patients. Key words Health management;Fatty liver;Quality of life 脂肪肝是一種较为常见的肝脏疾病，其根本致病原因在于肝细胞内脂肪堆积过多。近年来，脂肪肝发病率呈现上升趋势。在我国脂肪肝已经成为了仅次于病毒性肝炎的第二大肝脏疾病，对社会公众健康产生了严重的威胁，且